Analysts think PGEN stock price could increase by 140%
Dec 06, 2025, 12:25 PM
15.67%
What does PGEN do
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
4 analysts think PGEN stock price will increase by 140.50%. The current median analyst target is $8.67 compared to a current stock price of $3.60. The lowest analysts target is $8.08 and the highest analyst target is $9.45.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.